The stock of Rush Enterprises, Inc. (NASDAQ:RUSHB) reached all time high today, Apr, 25 and still has $37.67 target or 9.00% above today’s $34.56 share price. This indicates more upside for the $1.50 billion company. This technical setup was reported by Barchart.com. If the $37.67 PT is reached, the company will be worth $135.00M more. The stock increased 2.13% or $0.72 during the last trading session, reaching $34.56. About 33,446 shares traded or 10.11% up from the average. Rush Enterprises, Inc. (NASDAQ:RUSHB) has risen 42.60% since September 16, 2016 and is uptrending. It has outperformed by 31.62% the S&P500.
West Pharmaceutical Services, Inc. is a maker of packaging components and delivery systems for injectable drugs and healthcare products. The company has market cap of $6.12 billion. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. It has a 43.33 P/E ratio. The Company’s divisions include Proprietary Products and Contract-Manufactured Products.
Analysts await West Pharmaceutical Services Inc. (NYSE:WST) to report earnings on April, 27. They expect $0.55 earnings per share, up 3.77% or $0.02 from last year’s $0.53 per share. WST’s profit will be $40.62M for 37.67 P/E if the $0.55 EPS becomes a reality. After $0.54 actual earnings per share reported by West Pharmaceutical Services Inc. for the previous quarter, Wall Street now forecasts 1.85% EPS growth.
The stock increased 0.52% or $0.43 on April 25, reaching $82.87. About 328,844 shares traded. West Pharmaceutical Services Inc. (NYSE:WST) has risen 1.29% since September 16, 2016 and is uptrending. It has underperformed by 9.70% the S&P500.
Magee Thomson Investment Partners Llc holds 4.12% of its portfolio in West Pharmaceutical Services Inc. for 140,000 shares. Kalmar Investments Inc De owns 695,976 shares or 3.04% of their US portfolio. Moreover, Kistler has 3.02% invested in the company for 72,724 shares. The Massachusetts-based Copper Rock Capital Partners Llc has invested 1.84% in the stock. Ironbridge Capital Management Lp, a Illinois-based fund reported 393,029 shares.
Ratings analysis reveals 100% of West Pharmaceutical Services’s analysts are positive. Out of 2 Wall Street analysts rating West Pharmaceutical Services, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. WST was included in 5 notes of analysts from August 4, 2015. The company was initiated on Tuesday, March 22 by Wells Fargo. As per Wednesday, September 21, the company rating was downgraded by Wells Fargo. The stock of West Pharmaceutical Services Inc. (NYSE:WST) earned “Buy” rating by Janney Capital on Friday, January 8. The rating was upgraded by Wells Fargo on Friday, October 28 to “Outperform”. The rating was downgraded by Zacks to “Hold” on Tuesday, August 4.
Since January 1, 0001, it had 1 insider buy, and 1 insider sale for $159,032 activity.
Rush Enterprises, Inc. is an integrated retailer of commercial vehicles and related services. The company has market cap of $1.50 billion. The Firm operates through the Truck Segment, which includes its operation of a regional network of commercial vehicle dealerships under the name Rush Truck Centers. It has a 34.44 P/E ratio. Through its Rush Truck Centers, it offers services, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products.
